Problem Substance
Pioglitazone (trade Name Actos)
2 research abstracts
AI Summary
Key Findings
Research Overview
- Total Abstracts
- 2
- Action Type
- Problem Substance
- Natural Substances
- 1
- Diseases
- 9
- Articles
- 1
Pioglitazone (trade Name Actos) is an action with 2 research abstracts on GreenMedInfo. Explore the evidence-based research below covering 10 related substances and health topics.
Articles about Pioglitazone (trade Name Actos)
View all 1 articles
Jan 28, 2018
The Dangers of GMO Insulin for Type 2 Diabetics No One Talks About
A growing body of concerning research indicates that conventional medicine's standard of care for type 2 diabetes, including synthetic insulin and oral anti-diabetic drugs, may actually increase morbi...
GMI Research Group
10 min
Loading...
No found.
Loading ...
Related Topics
Thymoquinone
(1)
High Cholesterol
(1)
High Fructose Diet
(1)
Hyperglycemia
(1)
Insulin Resistance
(1)
Metabolic Diseases
(1)
Oxidative Stress
(1)
Triglycerides: Elevated
(1)
Weight Gain: Drug-Induced
(1)
Weight Problems: Drug-Induced
(1)
Substance
Health Topic
